Erratum to "Flow cytometric mean fluorescence intensity: The biophysics behind the number" [Leukemia Res. 32 (2008) 845-846] (DOI:10.1016/j.leukres.2007.10.002);Flow cytometric mean fluorescence intensity: The biophysics behind the number

Leukemia Research

Volumn 32, Issue 6, 2008, Pages 845-846

  A Wells, Denise ^a   Loken, Michael R ^a  

^a HEMATOLOGICS INC   (United States)

Author keywords

Acute myeloid leukemia; c kit; CD117; CD34; Flow cytometry; Mean fluorescence intensity; Prognosis; Quality control

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; CELL POPULATION; EDITORIAL; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; IMMUNOPHENOTYPING; PRIORITY JOURNAL; PROGNOSIS;

EID: 40849097525     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.06.021     Document Type: Erratum

References (15)

1. Smith F.O., Broudy V.C., Zsebo K.M., et al. Cell surface expression of c-kit receptors by childhood acute myeloid leukemia blasts is not of prognostic value: a report from the Childrens Cancer Group. Blood 84 (1994) 847-852
2. Smith F.O., Lampkin B.C., Versteeg C., et al. Expression of lymphoid-associated cell surface antigens by childhood acute myeloid leukemia cells lacks prognostic significance. Blood 79 (1992) 2415-2422
3. Scolnik M.P., Morilla R., de Bracco M.M., Catovsky D., and Matutes E. CD34 and CD117 are overexpressed in AML and may be valuable to detect minimal residual disease. Leuk Res 26 (2002) 615-619
4. Spoo A.C., Lubbert M., Wierda W.G., and Burger J.A. CXCR4 is a prognostic marker in acute myelogenous leukemia. Blood 109 (2007) 786-791
5. Borowitz M.J., Shuster J., Carroll A.J., et al. Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukaemia. A Pediatric Oncology Group Study. Blood 89 (1997) 3960-3966
6. Advani A.S., Rodriguez C., Jin T., Jawde R.A., Saber W., Baz R., Kalaycio M., Sobecks R., Sekeres M., Tripp B., and Hsi E. Increased C-kit Intensity is a Poor Prognostic Factor for Progression-Free and Overall Survival in Patients with Newly Diagnosed AML. Leuk Res 32 (2008) 913-918
7. Terstappen L.W., Safford M., Konemann S., et al. Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis. Leukemia 6 (1992) 70-80
8. Lanza F., Moretti S., Castagnari B., et al. CD34+ leukemic cells assessed by different CD34 monoclonal antibodies. Leuk Lymphoma 18 Suppl 1 (1995) 25-30
9. Maynadie M., Gerland L., Aho S., et al. Clinical value of the quantitative expression of the three epitopes of CD34 in 300 cases of acute myeloid leukemia. Haematologica 87 (2002) 795-803
10. Schwartz A., Fernandez Repollet E., Vogt R., and Gratama J.W. Standardizing flow cytometry: construction of a standardized fluorescence calibration plot using matching spectral calibrators. Cytometry 26 (1996) 22-31
11. Schwartz A., Ottinger J., Wallace E., Poon R., and Fernandez-Repollet E. Quantitative determination of antibody binding capacity (ABC) by flow cytometry. Eur J Histochem 38 Suppl 1 (1994) 13-20
12. CaLSI. C. Clinical flow cytometry analysis of neoplastic haematolymphoid cells-approved guideline. 2nd ed. Pennsylvania 19087-1898, USA: Wayne; 2006. ISBN 1-56238-000-0 [CLSI Document H43-A2].
13. Ratei R., Karawajew L., Lacombe F., et al. Normal lymphocytes from leukemic samples as an internal quality control for fluorescence intensity in immunophenotyping of acute leukemias. Cytometry B Clin Cytom 70 (2006) 1-9
14. Iyer S.B., Hultin L.E., Zawadzki J.A., Davis K.A., and Giorgi J.V. Quantitation of CD38 expression using QuantiBRITE beads. Cytometry 33 (1998) 206-212
15. Schmid I., Schmid P., and Giorgi J.V. Conversion of logarithmic channel numbers into relative linear fluorescence intensity. Cytometry 9 (1988) 533-538